Pharma channel feed

Q&A: San­doz CEO Richard Saynor on gener­ic GLP-1s, Trump's in­dus­try im­pact, and Mark Cuban's com­pa­ny

Last month
People
Manufacturing

En­her­tu com­bo has the mak­ings of a new stan­dard in HER2-pos­i­tive breast can­cer

Last month
R&D

Bris­tol My­ers bets $1.5B on BioN­Tech's PD-L1xVEGF from Bio­theus

Last month
Deals
China

Ve­ra posts pos­i­tive Phase 3 rare kid­ney dis­ease da­ta, but crowd­ed mar­ket looms

Last month
R&D

FDA ap­proves Mod­er­na’s next-gen Covid vac­cine, with lim­its on most healthy peo­ple

Last month
FDA+

En­her­tu ex­tends life by three months for some stom­ach can­cer pa­tients, study finds

Last month
R&D

Gilead, Mer­ck re­veal 'prac­tice-chang­ing' da­ta for Trodelvy-Keytru­da com­bo in ag­gres­sive breast can­cer

Last month
R&D

Trump ad­min­is­tra­tion los­es bid to move ahead with HHS fir­ings, re­or­ga­ni­za­tion

Last month
Law

As­traZeneca agrees to pay $51M to set­tle ‘pay-for-de­lay’ class ac­tion suit

Last month
Law

HHS says it's pulled Covid shot guid­ance for healthy kids. The CDC vac­cine sched­ule shows oth­er­wise

Last month
FDA+

As a chal­leng­ing first half nears a close, bio­phar­ma un­cer­tain­ty per­sists

Last month
Financing
Deals

Pfiz­er's Braftovi com­bo dou­bles sur­vival time for some col­orec­tal can­cer pa­tients

Last month
R&D

Supreme Court to keep mulling state PBM dis­pute as US urges jus­tices to de­cline case

Last month
Law

Ei­sai, Mer­ck stave off gener­ic com­pe­ti­tion to block­buster can­cer drug Lenvi­ma

Last month
Law

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

Last month
Manufacturing

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

Last month
R&D

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

Last month
Coronavirus

No­vo Nordisk ‘strong­ly’ urges against phar­ma tar­iffs as com­ments flood in

Last month
Manufacturing

A new dawn for psy­che­delics? Com­pass could be the first to find out

Last month
In Focus

Ax­some and Het­ero set­tle patent fight over sleep dis­or­der drug

Last month
Law

FDA re­jects Savara’s rare lung dis­ease drug over lim­it­ed man­u­fac­tur­ing da­ta

Last month
FDA+
Manufacturing

Lil­ly to buy non-opi­oid pain biotech SiteOne for up to $1B

Last month
Deals

Liq­uidia wins ap­proval for in­haled hy­per­ten­sion drug in two set­tings, fur­ther­ing ri­val­ry with Unit­ed Ther­a­peu­tics

Last month
FDA+

Bio­gen taps City Ther­a­peu­tics in RNAi deal worth up to $1B

Last month
Startups
Deals
First page Previous page 2345678 Next page Last page
A service from the Financial Times